CHLORHEXIDINE GLUCONATE

Post-LOE

chlorhexidine gluconate 0.12% oral rinse

Molecular Devices

ANDADENTALSOLUTION

Approved

Dec 1995

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

CHLORHEXIDINE GLUCONATE (chlorhexidine gluconate 0.12% oral rinse) by Molecular Devices is clinical pharmacology chlorhexidine gluconate provides antimicrobial activity during oral rinsing. First approved in 1995.

Drug data last refreshed 19h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Chlorhexidine gluconate provides antimicrobial activity during oral rinsing. The clinical significance of chlorhexidine gluconate's antimicrobial activities is not clear. Microbiological sampling of plaque has shown a general reduction of counts of certain assayed bacteria,…

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Company

Worked on CHLORHEXIDINE GLUCONATE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.